HARVARD BIOSCIENCE, INC. (HBIO)

8.02USD +0.25% (+0.02)

Over 1M: +24.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

6 7 8
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 20.6M Q3 '25 — Operating Income: 197K Q4 '25 — Revenue: 23.7M Q4 '25 — Operating Income: 1.7M Q1 '26 — Revenue: 20.8M Q1 '26 — Operating Income: -1.2M Q2 '26 — Revenue: 22.7M Q2 '26 — Operating Income: -978K 0 5M 10M 15M 20M 25M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.5
Oper. margin -0.28%
ROIC -0.51%
OE margin -2.9%
Accruals -14.5%
Gross margin 58.2%
ROCE -0.48%
FCF margin -1.3%
OCF margin 0.74%
Profit margin -11.9%
ROA -13.6%
ROE -140.4%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 0.76×
EV/OE -26.3×
EV/GP 1.3×
P/C 5.6×
P/B 4.9×
FCF yield -3.1%
Div. yield —
EV/EBIT —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.8
RPO / sales 0.026×
RPO growth 36.9%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.1
ND/EBITDA -0.45
Interest cover -0.053×
Cash / Debt 0.18×
Quick ratio 0.98×
Debt / Eq 4.9×
F-score 4.0 pts
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.1
Sales/sh Y/Y -3.0%
Sales Q/Q +11.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.